Ryan N. Henderson

Array ( [id] => 6737137 [patent_doc_number] => 20030014772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Transgenic mice containing MSK2 serine/threonine kinase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/112286 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22512 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20030014772.pdf [firstpage_image] =>[orig_patent_app_number] => 10112286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6746816 [patent_doc_number] => 20030023999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Transgenic mice containing GNB1 gene disruptions' [patent_app_type] => new [patent_app_number] => 10/109579 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22122 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023999.pdf [firstpage_image] =>[orig_patent_app_number] => 10109579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6737134 [patent_doc_number] => 20030014769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Transgenic mice containing GPCR-like transmembrane protein disruptions' [patent_app_type] => new [patent_app_number] => 10/108751 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21218 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20030014769.pdf [firstpage_image] =>[orig_patent_app_number] => 10108751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6757697 [patent_doc_number] => 20030005474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'ADAM-like protease disruptions, compositions and methods related thereto' [patent_app_type] => new [patent_app_number] => 10/109548 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26166 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20030005474.pdf [firstpage_image] =>[orig_patent_app_number] => 10109548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6775649 [patent_doc_number] => 20030018988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Transgenic mice containing mGluR7 metabotropic glutamate receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 10/109529 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23535 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018988.pdf [firstpage_image] =>[orig_patent_app_number] => 10109529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6831617 [patent_doc_number] => 20030182675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Functional disruption of avian immunoglobulin genes' [patent_app_type] => new [patent_app_number] => 10/104486 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14431 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20030182675.pdf [firstpage_image] =>[orig_patent_app_number] => 10104486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609920 [patent_doc_number] => 06998266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => 'Active retinoic acid-free culture medium for avian totipotent embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 10/097245 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 5976 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998266.pdf [firstpage_image] =>[orig_patent_app_number] => 10097245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860536 [patent_doc_number] => 20030091544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Interferon-Beta polynucleotide therapy for autoimmune and inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/096373 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23918 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091544.pdf [firstpage_image] =>[orig_patent_app_number] => 10096373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536843 [patent_doc_number] => 20020193333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method of delivering genes into antigen presenting cells of the skin' [patent_app_type] => new [patent_app_number] => 10/081922 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9732 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193333.pdf [firstpage_image] =>[orig_patent_app_number] => 10081922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5791834 [patent_doc_number] => 20020162124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds' [patent_app_type] => new [patent_app_number] => 10/062225 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14095 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20020162124.pdf [firstpage_image] =>[orig_patent_app_number] => 10062225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821084 [patent_doc_number] => 20060025397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Method of resistance of epilepsy by suppressing the function of alpha 1g protein' [patent_app_type] => utility [patent_app_number] => 10/493376 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6026 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025397.pdf [firstpage_image] =>[orig_patent_app_number] => 10493376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679173 [patent_doc_number] => 20030167479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Vascular endothelial zinc finger 1 gene and protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/053291 [patent_app_country] => US [patent_app_date] => 2002-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13441 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20030167479.pdf [firstpage_image] =>[orig_patent_app_number] => 10053291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 506756 [patent_doc_number] => 07202392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'In vivo screening array' [patent_app_type] => utility [patent_app_number] => 10/470818 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3749 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202392.pdf [firstpage_image] =>[orig_patent_app_number] => 10470818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5791857 [patent_doc_number] => 20020162134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Primordial germ cell-based germ line production of birds' [patent_app_type] => new [patent_app_number] => 10/044006 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10430 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20020162134.pdf [firstpage_image] =>[orig_patent_app_number] => 10044006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830345 [patent_doc_number] => 20030181403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Products and methods for controlling the suppression of the neoplastic phenotype' [patent_app_type] => new [patent_app_number] => 10/028726 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21611 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181403.pdf [firstpage_image] =>[orig_patent_app_number] => 10028726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655989 [patent_doc_number] => 20030106073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Transgenic mice containing FPR-RS4 gene disruptions' [patent_app_type] => new [patent_app_number] => 10/026937 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22254 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20030106073.pdf [firstpage_image] =>[orig_patent_app_number] => 10026937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538159 [patent_doc_number] => 20020137203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Transgenic mice containing alpha-endosulfine gene disruptions' [patent_app_type] => new [patent_app_number] => 10/016993 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137203.pdf [firstpage_image] =>[orig_patent_app_number] => 10016993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679159 [patent_doc_number] => 20030167493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Transgenic mice containing GPRC5B-like gene disruptions' [patent_app_type] => new [patent_app_number] => 10/016656 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20769 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20030167493.pdf [firstpage_image] =>[orig_patent_app_number] => 10016656 [rel_patent_id] =>[rel_patent_doc_number] =>)